Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-12

Clinical Trial Update: The Genetic Basis for Vulnerability to Substance Abuse

View source ↗

Summary

This clinical trial investigated genetic factors that influence vulnerability to substance use disorders and was sponsored by NIDA; the study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Substance Abuse | Status: COMPLETED